Uterine Fibroids. What We Know and What We Need to Know

Uterine Fibroids. What We Know and What We Need to Know

Maria Korchagina

Contact

Uterine Fibroids. What We Know and What We Need to Know

Article Fingerprint

ReserarchID

4F5J2

Uterine Fibroids. What We Know and What We Need to Know Banner

AI TAKEAWAY

Connecting with the Eternal Ground

Abstract

Uterine fibroids (UFs) are the most common tumours of the female reproductive system and represent a significant health issue worldwide. UFs develop during reproductive span and often shrink after menopause.UFs affect over 70% of women by the onset of menopause. Uterine fibroids arise from myometrial smooth muscle cells. UFs can be solitary or multiply and their size varies from microscopic to giant. Nowadays the exact cause of UFs remains unknown, but it is assumed that genetic abberations along with steroid hormones and growth factors play a pivotal role in thetumour development. In most cases UFs are asymptomaticand therefore it is difficult to estimate their actual prevalence. Symptomatic UFs present with abnormal menstrual bleeding, pelvic and low back pain, bulk symptoms, infertility and have a strong impact on health-related-quality-of-life (HRQL). Early diagnosisand treatment of UFs as well as preventive measures, especially for patients from high-risk groups, should be a priority. This article presents current data about pathophysiology, diagnosisandmanagement of UFs.

References

96 Cites in Article

Reference Format

Aamir Khan,Manjeet Shehmar,Janesh Gupta (2014). Uterine fibroids: current perspectives.
D Baird,D Dunson,M Hill,D Cousins,J Schectman (2003). High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
E Stewart,C Cookson,R Gandolfo,R Schulze-Rath (2017). Epidemiology of uterine fibroids: a systematic review.
Sarah Holdsworth-Carson,Marina Zaitseva,Beverley Vollenhoven,Peter Rogers (2014). Clonality of smooth muscle and fibroblast cell populations isolated from human fibroid and myometrial tissues.
W Qiang,Z Liu,V Serna (2014). Down-regulation of miR-29b is essential for pathogenesis of uterine leiomyoma.
William Parker (2007). Etiology, symptomatology, and diagnosis of uterine myomas.
D Markowski,B Helmke,G Belge (2011). HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications.
Priya Mittal,Yong-Hyun Shin,Svetlana Yatsenko,Carlos Castro,Urvashi Surti,Aleksandar Rajkovic (2015). Med12 gain-of-function mutation causes leiomyomas and genomic instability.
Natalia Osinovskaya,Olga Malysheva,Natalia Shved,Tatyana Ivashchenko,Iskender Sultanov,Olga Efimova,Maria Yarmolinskaya,Vitaly Bezhenar,Vladislav Baranov (2016). Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.
Andrea Ciavattini,Jacopo Di Giuseppe,Piergiorgio Stortoni,Nina Montik,Stefano Giannubilo,Pietro Litta,Md. Islam,Andrea Tranquilli,Fernando Reis,Pasquapina Ciarmela (2013). Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction.
Elizabeth Bertsch,Wenan Qiang,Qing Zhang,Margarita Espona-Fiedler,Stacy Druschitz,Yu Liu,Khush Mittal,Beihua Kong,Takeshi Kurita,Jian-Jun Wei (2014). MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.
Luis Galindo,Tamara Hernández-Beeftink,Ana Salas,Yaiza Jung,Ricardo Reyes,Francisco De Oca,Mariano Hernández,Teresa Almeida (2018). HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
Paolo Chieffi,Sabrina Battista,Marco Barchi,Silvia Di Agostino,Giovanna Pierantoni,Monica Fedele,Lorenzo Chiariotti,Donatella Tramontano,Alfredo Fusco (2002). HMGA1 and HMGA2 protein expression in mouse spermatogenesis.
Nihan Ozturk,Indrabahadur Singh,Aditi Mehta,Thomas Braun,Guillermo Barreto (2014). HMGA proteins as modulators of chromatin structure during transcriptional activation.
Silvia Parisi,Silvia Piscitelli,Fabiana Passaro,Tommaso Russo (2020). HMGA Proteins in Stemness and Differentiation of Embryonic and Adult Stem Cells.
Raymond Reeves,Lois Beckerbauer (2001). HMGI/Y proteins: flexible regulators of transcription and chromatin structure.
B Helmke,D Markowski,M Muller,A Sommer,J Muller,C Moller,J Bullerdiek (2011). HMGA proteins regulate the expression of FGF2 in uterine fibroids.
Gregory Kirschen,Abdelrahman Alashqar,Mariko Miyashita-Ishiwata,Lauren Reschke,Malak El Sabeh,Mostafa Borahay (2021). Vascular biology of uterine fibroids: connecting fibroids and vascular disorders.
Netta Mäkinen,Miika Mehine,Jaana Tolvanen,Eevi Kaasinen,Yilong Li,Heli Lehtonen,Massimiliano Gentile,Jian Yan,Martin Enge,Minna Taipale,Mervi Aavikko,Riku Katainen,Elina Virolainen,Tom Böhling,Taru Koski,Virpi Launonen,Jari Sjöberg,Jussi Taipale,Pia Vahteristo,Lauri Aaltonen (1979). <i>MED12</i> , the <i>Mediator Complex Subunit 12</i> Gene, Is Mutated at High Frequency in Uterine Leiomyomas.
Abdeljabar El Andaloussi,Ayman Al-Hendy,Nahed Ismail,Thomas Boyer,Sunil Halder (2020). Introduction of Somatic Mutation in MED12 Induces Wnt4/β-Catenin and Disrupts Autophagy in Human Uterine Myometrial Cell.
Ning Luo,Qiyu Guan,Lihua Zheng,Xiaoyan Qu,Hong Dai,Zhongping Cheng (2014). Estrogen-mediated activation of fibroblasts and its effects on the fibroid cell proliferation.
Hiroshi Ishikawa,Kazutomo Ishi,Vanida Serna,Rafael Kakazu,Serdar Bulun,Takeshi Kurita (2010). Progesterone Is Essential for Maintenance and Growth of Uterine Leiomyoma.
B Gellersen,M Fernandes,J Brosens (2009). Non-genomic progesterone actions in female reproduction.
Jennifer Richer,Britta Jacobsen,Nicole Manning,M Abel,Kathryn Horwitz,Douglas Wolf (2002). Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells.
Paloma Giangrande,Giuseppe Pollio,Donald Mcdonnell (1997). Mapping and Characterization of the Functional Domains Responsible for the Differential Activity of the A and B Isoforms of the Human Progesterone Receptor.
Anna Hoekstra,Elizabeth Sefton,Emily Berry,Zhenxiao Lu,Jennifer Hardt,Erica Marsh,Ping Yin,Jon Clardy,Debabrata Chakravarti,Serdar Bulun,J Kim (2009). Progestins Activate the AKT Pathway in Leiomyoma Cells and Promote Survival.
Takeshi Maruo (2007). Progesterone and progesterone receptor modulator in uterine leiomyoma growth.
Mona Omar,Archana Laknaur,Ayman Al-Hendy,Qiwei Yang (2019). Myometrial progesterone hyper-responsiveness associated with increased risk of human uterine fibroids.
S Bulun,M Moravek,P Yin (2015). Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
Masanori Ono,Serdar Bulun,Tetsuo Maruyama (2014). Tissue-Specific Stem Cells in the Myometrium and Tumor-Initiating Cells in Leiomyoma1.
Aymara Mas,Irene Cervello,Claudia Gil-Sanchis,Carlos Simón (2014). Current understanding of somatic stem cells in leiomyoma formation.
Li-Hua Zheng,Feng-Feng Cai,Isabell Ge,Ewelina Biskup,Zhong-Ping Cheng (2014). Stromal fibroblast activation and their potential association with uterine fibroids (Review).
Yosuke Shimomura,Hiroya Matsuo,Takasi Samoto,Takesi Maruo (1998). Up-Regulation by Progesterone of Proliferating Cell Nuclear Antigen and Epidermal Growth Factor Expression in Human Uterine Leiomyoma1.
Pasquapina Ciarmela,Enrrico Bloise,Peter Gray,Patrizia Carrarelli,Md. Islam,Flavio De Pascalis,Filiberto Severi,Wylie Vale,Mario Castellucci,Felice Petraglia (2011). Activin-A and Myostatin Response and Steroid Regulation in Human Myometrium: Disruption of Their Signalling in Uterine Fibroid.
Se-Jin Lee,Yun-Sil Lee,Teresa Zimmers,Arshia Soleimani,Martin Matzuk,Kunihiro Tsuchida,Ronald Cohn,Elisabeth Barton (2010). Regulation of Muscle Mass by Follistatin and Activins.
Mostafa Borahay,Ayman Al-Hendy,Gokhan Kilic,Darren Boehning (2015). Signaling Pathways in Leiomyoma: Understanding Pathobiology and Implications for Therapy.
Olga Protic,Paolo Toti,Md Islam,Rossella Occhini,Stefano Giannubilo,William Catherino,Saverio Cinti,Felice Petraglia,Andrea Ciavattini,Mario Castellucci,Boris Hinz,Pasquapina Ciarmela (2016). Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.
Yong Kim,Yoon Kim,Jung Shin,Hoon Kim,Seung-Yup Ku,Chang Suh (2018). Variation in MicroRNA Expression Profile of Uterine Leiomyoma with Endometrial Cavity Distortion and Endometrial Cavity Non-Distortion.
Shannon Laughlin‐tommaso,Gina Hesley,Matthew Hopkins,Kathleen Brandt,Yunxiao Zhu,Elizabeth Stewart (2017). Clinical limitations of the International Federation of Gynecology and Obstetrics (<scp>FIGO</scp>) classification of uterine fibroids.
Hao Qin,Zhijuan Lin,Elizabeth Vásquez,Xiao Luan,Feifei Guo,Luo Xu (2021). Association between obesity and the risk of uterine fibroids: a systematic review and meta-analysis.
R Ross,M Pike,M Vessey,D Bull,D Yeates,J Casagrande (1986). Risk factors for uterine fibroids: reduced risk associated with oral contraceptives..
Kathryn Terry,Immaculata De Vivo,Susan Hankinson,Stacey Missmer (2010). Reproductive characteristics and risk of uterine leiomyomata.
Eduardo Faerstein,Moyses Szklo,Neil Rosenshein (2001). Risk Factors for Uterine Leiomyoma: A Practice-based Case-Control Study. II. Atherogenic Risk Factors and Potential Sources of Uterine Irritation.
Lauren Wise,Julie Palmer,Elizabeth Stewart,Lynn Rosenberg (2007). Polycystic ovary syndrome and risk of uterine leiomyomata.
Abdelrahman Alashqar,Kristin Patzkowsky,Sadia Afrin,Robert Wild,Hugh Taylor,Mostafa Borahay (2019). Cardiometabolic Risk Factors and Benign Gynecologic Disorders.
Anne Zimmermann,David Bernuit,Christoph Gerlinger,Matthias Schaefers,Katharina Geppert (2012). Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women.
Tchente Nguefack,C Fogaing,A Tejiokem,M,Nana Njotang,P Mbu,R Leke,R (2009). Pregnancy outcome in a group of Cameroonian women with uterine fibroids.
Julius Dohbit,Esther Meka,Joel Tochie,Igor Kamla,Celestin Danwang,Frank-Leonel Tianyi,Pascal Foumane,Gervais Andze (2019). Diagnostic ambiguity of aseptic necrobiosis of a uterine fibroid in a term pregnancy: a case report.
Pietro Foti,Massimo Tonolini,Valeria Costanzo,Luca Mammino,Stefano Palmucci,Antonio Cianci,Giovanni Ettorre,Antonio Basile (2019). Cross-sectional imaging of acute gynaecologic disorders: CT and MRI findings with differential diagnosis—part II: uterine emergencies and pelvic inflammatory disease.
M Roberts,J Aynardi,C Chu (2018). Uterine leiomyosarcoma: A review of the literature and update on management options.
Geum Sohn,Sihyun Cho,Yong Kim,Chi-Heum Cho,Mee-Ran Kim,Sa Lee (2018). Current medical treatment of uterine fibroids.
Anne Lethaby,Lucian Puscasiu,Beverley Vollenhoven (2017). Preoperative medical therapy before surgery for uterine fibroids.
Sejal Patel (2009). Response of the Uterus to Medication: Hysteroscopic Implications.
Satoshi Ichigo,Hiroshi Takagi,Kazutoshi Matsunami,Noriko Suzuki,Atsushi Imai (2011). Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist.
Linda Bradley (2009). Investigation of Abnormal Uterine Bleeding in Premenopausal Women.
Rafael Moroni,Wellington Martins,Rui Ferriani,Carolina Vieira,Carolina Nastri,Francisco Candido Dos Reis,Luiz Brito (2015). Add-back therapy with GnRH analogues for uterine fibroids.
Giulio Formoso,Enrica Perrone,Susanna Maltoni,Sara Balduzzi,Jack Wilkinson,Vittorio Basevi,Anna Marata,Nicola Magrini,Roberto D'amico,Chiara Bassi,Emilio Maestri (2016). Short-term and long-term effects of tibolone in postmenopausal women.
Md Islam,Sadia Afrin,Sara Jones,James Segars (2020). Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility.
Thomas Rabe,Nicole Saenger,Andreas Ebert,Thomas Roemer,Hans-Rudolf Tinneberg,Rudy De Wilde,Markus Wallwiener (2018). Selective Progesterone Receptor Modulators for the Medical Treatment of Uterine Fibroids with a Focus on Ulipristal Acetate.
A Puchar,D Luton,M Koskas (2015). Ulipristal acetate for uterine fibroid-related symptoms.
Lynnette Nieman,Wendy Blocker,Tonja Nansel,Sheila Mahoney,James Reynolds,Diana Blithe,Robert Wesley,Alicia Armstrong (2011). Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study.
N Biglia,S Carinelli,A Maiorana,D' Alonzo,M,Lo Monte,G,Marci (2014). Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids.
J Donnez,M Dolmans (2016). Uterine fibroid management: from the present to the future.
Jacques Donnez,Olivier Donnez,Dace Matule,Hans-Joachim Ahrendt,Robert Hudecek,Janos Zatik,Zaneta Kasilovskiene,Mihai Dumitrascu,Hervé Fernandez,David Barlow,Philippe Bouchard,Bart Fauser,Elke Bestel,Ernest Loumaye (2016). Long-term medical management of uterine fibroids with ulipristal acetate.
Jacques Donnez,Olivier Donnez,Marie-Madeleine Dolmans (2016). What Is the Place of Myoma Surgery with the Advent of Selective Progesterone Receptor Modulators (SPRMs)?.
Jacques Donnez,Janusz Tomaszewski,Francisco Vázquez,Philippe Bouchard,Boguslav Lemieszczuk,Francesco Baró,Kazem Nouri,Luigi Selvaggi,Krzysztof Sodowski,Elke Bestel,Paul Terrill,Ian Osterloh,Ernest Loumaye (2012). Ulipristal Acetate versus Leuprolide Acetate for Uterine Fibroids.
Linyu Deng,Taixiang Wu,Xiao Chen,Lingxia Xie,Jinrong Yang (2012). Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Huan Song,Donghao Lu,Kate Navaratnam,Gang Shi (2013). Aromatase inhibitors for uterine fibroids.
George Vilos,Catherine Allaire,Philippe-Yves Laberge,Nicholas Leyland,Angelos Vilos,Ally Murji,Innie Chen (2015). The Management of Uterine Leiomyomas.
Aymara Mas,Marta Tarazona,Joana Dasí Carrasco,Gloria Estaca,Ignacio Cristóbal,Javier Monleón (2017). Updated approaches for management of uterine fibroids.
Myo Kim,You Uhm,Ju Kim,Byung Jee,Yong Kim (2013). Obstetric outcomes after uterine myomectomy: Laparoscopic versus laparotomic approach.
Mark Glasser (2005). Minilaparotomy myomectomy: A minimally invasive alternative for the large fibroid uterus.
Kinga Księżakowska-Łakoma,Monika Żyła,Jacek Wilczyński (2015). Removal of uterine fibroids by mini-laparotomy technique in women who wish to preserve their uterus and fertility..
Bhave Chittawar,P Franik,S Pouwer,A Farquhar,C (2014). Minimally invasive surgical techniques versus open myomectomy for uterine fibroids.
Anja Herrmann,Rudy De Wilde (2014). Laparoscopic myomectomy—The gold standard.
Probo Yudha Pratama Putra,Arlinda Prameswari,Mochammad Ma'roef,Aida Musyarrofah,Halida Nelasari (2021). Laparoscopic myomectomy versus open myomectomy in uterine fibroid treatment: A meta-analysis.
Ji Tan,Yangyan Sun,Huihua Dai,Baoliang Zhong,Daoyuan Wang (2008). A Randomized Trial of Laparoscopic Versus Laparoscopic-Assisted Minilaparotomy Myomectomy for Removal of Large Uterine Myoma: Short-Term Outcomes.
J Magrina (2007). Robotic surgery in gynecology.
E Barakat,M Bedaiwy,S Zimberg,B Nutter,M Nosseir,T Falcone (2011). Robotic-assisted, laparoscopic, and abdominal myomectomy: a comparison of surgical outcomes.
Lili Jiang,Deming Tong,Yan Li,Qifang Liu,Kuiran Liu (2021). Application of Single-Port Laparoscopic Surgery in Myomectomy.
Jin-Sung Yuk,Hyun Ji,Kye Kim,Jung Lee (2015). Single-port laparoscopically assisted-transumbilical ultraminilaparotomic myomectomy (SPLA-TUM) versus single port laparoscopic myomectomy: a randomized controlled trial.
J Ravina,N Ciraru-Vigneron,J Bouret,D Herbreteau,E Houdart,A Aymard,J Merland (1995). Arterial embolisation to treat uterine myomata.
Janesh Gupta,Anju Sinha,M Lumsden,Martha Hickey (2012). Uterine artery embolization for symptomatic uterine fibroids.
Janesh Gupta,Anju Sinha,M Lumsden,Martha Hickey (2014). Uterine artery embolization for symptomatic uterine fibroids.
Juraci Ghiaroni,Gaudencio Lopez,Antonio Coutinho Junior,Alberto Schanaider (2013). Embolização das artérias uterinas com partículas de PVA-PVAC esférico como preparo para posterior ressecção cirúrgica de miomas.
T Ukybassova,M Terzic,J Dotlic (2019). Evaluation of Uterine Artery Embolization on Myoma Shrinkage: Results from a Large Cohort Analysis.
Bruce Mclucas,William Voorhees Iii,Stephanie Elliott (2015). Fertility after uterine artery embolization: a review.
Olivier Serres-Cousine,Fiene Kuijper,Emmanuel Curis,Diana Atashroo (2021). Clinical investigation of fertility after uterine artery embolization.
Kirsten Hald,Anton Langebrekke,Nils Kløw,Hans Noreng,Anette Berge,Olav Istre (2004). Laparoscopic occlusion of uterine vessels for the treatment of symptomatic fibroids: Initial experience and comparison to uterine artery embolization.
Weihong Yang,Ning Luo,Zhongping Cheng (2016). Laparoscopic uterine artery occlusion for the treatment of symptomatic uterine fibroids.
Gina Hesley,Joel Felmlee,John Gebhart,Kelly Dunagan,Krzysztof Gorny,Jessica Kesler,Kathleen Brandt,Janel Glantz,Bobbie Gostout (2006). Noninvasive Treatment of Uterine Fibroids: Early Mayo Clinic Experience With Magnetic Resonance Imaging-Guided Focused Ultrasound.
Jaron Rabinovici,Matthias David,Hidenobu Fukunishi,Yutaka Morita,Bobbie Gostout,Elizabeth Stewart (2010). Pregnancy outcome after magnetic resonance–guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids.
Miriam Hanstede,Clare Tempany,Elizabeth Stewart (2007). Focused ultrasound surgery of intramural leiomyomas may facilitate fertility: A case report.
Esther Bouwsma,Krzysztof Gorny,Gina Hesley,Jani Jensen,Lisa Peterson,Elizabeth Stewart (2011). Magnetic resonance-guided focused ultrasound surgery for leiomyoma-associated infertility.
Gale Harding,Karin Coyne,Christine Thompson,James Spies (2008). The responsiveness of the uterine fibroid symptom and health-related quality of life questionnaire (UFS-QOL).
A Baratov,F Rakhimov,E Kalmykov (2020). ASSESSMENT OF THE UFS-QOL QUESTIONNAIRE BEFORE AND AFTER UTERINE ARTERY EMBOLIZATION FOR UTERINE LEIOMYOMA.

Download References

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Maria Korchagina. 2026. \u201cUterine Fibroids. What We Know and What We Need to Know\u201d. Global Journal of Medical Research - E: Gynecology & Obstetrics GJMR-E Volume 22 (GJMR Volume 22 Issue E2).

More Citation Formats

Select Citation Style:

Download Citation

GJMR Volume 22 Issue E2

Explore Journals Explore Volume Read This Issue

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords

Not Found

Classification

GJMR-E Classification DDC Code: 618.175 LCC Code: RG186

Submission ReceivedFebruary 17, 2022
Peer Review Double Blind
Handling Editor
Accepted February 25, 2022
Published July 9, 2022

Version of record

v1.2

Issue date

July 9, 2022

Language

Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

View in VR

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

View in 3D

Article Matrices

Total Views: 1592

Total Downloads: 40

2026 Trends

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]